Triterpenoids with neurotrophic activity from Ganoderma lucidum

Natural Product Research

Volumn 25, Issue 17, 2011, Pages 1607-1613

  Zhang, Xiao Qi ^a   Ip, Fanny C F ^b   Zhang, Dong Mei ^a   Chen, Li Xin ^a   Zhang, Wei ^a   Li, Yao Lan ^a   Ip, Nancy Y ^b   Ye, Wen Cai ^a  

^a JINAN UNIVERSITY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

4,4,14 trimethyl 5 chol 7, 9(11) dien 3 oxo 24 oic acid; Ganoderma lucidum; Neurotrophic activity; Triterpenoid

Indexed keywords

4,4,14ALPHA TRIMETHYL 5ALPHA CHOL 7,9(11) DIEN 3 OXO 24 OIC ACID; 7 OXO GANODERIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GANODERIC ACID S1; GANODERMA LUCIDUM EXTRACT; GANODERMATRIOL; GANODERMIC ACID TQ; GANOLUCIDIC ACID A; LANOSTANOID; METHYL GANODERIC ACID A; METHYL GANODERIC ACID B; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL STRAIN 3T3; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; FRUITING BODY; GANODERMA LUCIDUM; MASS SPECTROMETRY; MOUSE; NEUROTROPISM; NONHUMAN;

GANODERMA LUCIDUM;

EID: 80155178916     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2010.496367     Document Type: Article

References (22)

1. Arisawa, M., Fujita, A., Saga, M., Fukumura, H., Hayashi, T., Shimizu, M., & Morita, N. (1986). Three new lanostanoids from Ganoderma lucidum. Journal of Natural Products, 49, 621-625. (Pubitemid 16001135)
2. Barbacid, M. (1994). The Trk family of neurotrophin receptors. Journal of Neurobiology, 25, 1386-1403. (Pubitemid 24325064)
3. Blesch, A. (2006). Neurotrophic factors in neurodegeneration. Brain Pathology, 16, 295-303. (Pubitemid 44780720)
4. Glass, D.J., Nye, S.H., Hantzopoulos, P., Macchi, M.J., Squinto, S.P., Goldfarb, M., & Yancopoulous, D.G. (1991). Trkl3 mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell, 66, 405-413. (Pubitemid 121001377)
5. Jones, K. (1998). Reishi mushroom. Alternative and Complementary Therapies, 4, 256-266.
6. Kikuchi, T., Kanomi, S., Kadota, S., Murai, Y., Tsubono, K., & Ogita, Z. (1986a). Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I: structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds. Chemical & Pharmaceutical Bulletin, 34, 3695-3712. (Pubitemid 17192762)
7. Kikuchi, T., Kanomi, S., Murai, Y., Kadota, S., Tsubono, K., & Ogita, Z. (1986b). Constituents of the fungus Ganoderma lucidum (Fr.) Karst. III: structures of ganolucidic acids A and B, new lanostane-type triterpenoids. Chemical & Pharmaceutical Bulletin, 34, 4030-4036.
8. Kim, R.S., Kim, H.W., & Kim, B.K. (1997). Suppressive effects of Ganoderma lucidum on proliferation of peripheral blood mononuclear cells. Molecules and Cells, 7, 52-57. (Pubitemid 127484271)
9. Kohda, H., Tokumoto, W., & Sakamoto, K. (1985). The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. Chemical & Pharmaceutical Bulletin, 33, 1367-1374. (Pubitemid 15048664)
10. Li, C.J., Li, Y.M., & Sun, H.H. (2006). New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Natural Product Research, 20, 985-991. (Pubitemid 44566676)
11. Li, C.-J., Yin, J.-H., Guo, F.-J., Zhang, D.-C., & Sun, H.-H. (2005). Ganoderic acid Sz, a new lanostanoid from the mushroom Ganoderma lucidum. Natural Product Research, 19, 461-465.
12. Lin, Z.-B. (2001). Pharmacological functions of Ganoderma lucidum. In Z.-B. Lin (Ed.), Modern research of Ganoderma lucidum. Beijing: Beijing Medical University Press.
13. McKenna, D.J. (1998). In D.J. McKenna (Ed.), Natural dietary supplements: A desktop eference. St. Croix, U.S. Virgin Islands: Institute for Natural Products Research.
14. Morigiwa, A., Kitabatake, K., Fujimoto, Y., & Ikekawa, N. (1986). Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chemical & Pharmaceutical Bulletin, 34, 3025-3028. (Pubitemid 16001863)
15. Pan, Q., Ip, F.C., Ip, N.Y., Zhu, H.X., & Min, Z.D. (2004). Activity of macrocyclic jatrophane diterpenes from Euphorbia kansui in a TrkA fibroblast survival assay. Journal of Natural Products, 67, 1548-1551. (Pubitemid 39298625)
16. Price, R.D., Milne, S.A., Sharkey, J., & Matsuoka, N. (2007). Advances in small molecules promoting neurotrophic function. Pharmacology & Therapeutics, 115, 292-306. (Pubitemid 47042910)
17. Satoh, T. (2002). Neurotrophin-like low molecular weight compounds. Nippon Yakurigaku Zasshi, 120, 327-334. (Pubitemid 35332282)
18. Wang, S.Y., Hsu, M.L., Hsu, H.C., Tzeng, C.H., Lee, S.S., Shiao, M.S., & Ho, C.K. (1997). The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. International Journal of Cancer, 70, 699-705.
19. de Yebenes, J.G., & Mena, M.A. (2000). Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease. Neurotoxicity Research, 2, 115-137.
20. Yin, H., Wang, R., & Zhang, M. (2007). Brain-derived neurotrophic factor-like compounds, and application of screening system. Chinese Pharmacological Bulletin, 23, 1115-1118. (Pubitemid 47547076)
21. Zhang, X.-Q., Pang, G.-L., Cheng, Y., Wang, Y., & Ye, W.-C. (2008). Chemical constituents of the spores of Ganoderma lucidum. Journal of Chinese Medicinal Materials, 31, 41-44.
22. Zhao, J., Zhang, X.-Q., Li, S.-P., Yang, F.-Q., Wang, Y.-T., & Ye, W.-C. (2006). Quality evaluation of Ganoderma through simultaneous determination of nine triterpenes and sterols using pressurized liquid extraction and high performance liquid chromatography. Journal of Separation Science, 29, 2609-2615. (Pubitemid 46040156)